VERA
VERA
US92337R1014
Vera Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
315.473.000 167.170.000
88.7%
Operating Income -315.473.000 -167.170.000
88.7%
Pretax Income -299.614.000 -152.147.000
96.9%
Net Income Common Stockholders -299.615.000 -152.148.000
96.9%
-- --
--
-- --
--
ende